Cargando…

Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs

The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard me...

Descripción completa

Detalles Bibliográficos
Autores principales: Krekulová, Laura, Damajka, Tomáš, Krumphanslová, Zuzana, Řehák, Vratislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819867/
https://www.ncbi.nlm.nih.gov/pubmed/36612821
http://dx.doi.org/10.3390/ijerph20010501
_version_ 1784865333234892800
author Krekulová, Laura
Damajka, Tomáš
Krumphanslová, Zuzana
Řehák, Vratislav
author_facet Krekulová, Laura
Damajka, Tomáš
Krumphanslová, Zuzana
Řehák, Vratislav
author_sort Krekulová, Laura
collection PubMed
description The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard medical services. With this vision, we established an outreach service—a testing point in an ambulance in the park in front of the Main Railway Station of the capital city of Prague—to provide bloodborne disease testing and treatment. The service was available every week on Wednesday afternoon. Over the initial two years of our experience, 168 unique people were tested. Of them, 82 (49%) were diagnosed with chronic HCV infection and were eligible for treatment with antivirals. Of these, 24 (29%) initiated antiviral treatment over the study period, and 17 (71%) of these individuals achieved a documented sustained virological response. Offering medical services in PWIDs’ neighborhoods helps overcome barriers and increase the chances that they will become patients and begin HCV treatment. The described outcomes appear promising for reaching the vision of linkage to the care of such a hard-to-reach population and can serve as a feasible model of care for further expansion.
format Online
Article
Text
id pubmed-9819867
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98198672023-01-07 Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs Krekulová, Laura Damajka, Tomáš Krumphanslová, Zuzana Řehák, Vratislav Int J Environ Res Public Health Article The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard medical services. With this vision, we established an outreach service—a testing point in an ambulance in the park in front of the Main Railway Station of the capital city of Prague—to provide bloodborne disease testing and treatment. The service was available every week on Wednesday afternoon. Over the initial two years of our experience, 168 unique people were tested. Of them, 82 (49%) were diagnosed with chronic HCV infection and were eligible for treatment with antivirals. Of these, 24 (29%) initiated antiviral treatment over the study period, and 17 (71%) of these individuals achieved a documented sustained virological response. Offering medical services in PWIDs’ neighborhoods helps overcome barriers and increase the chances that they will become patients and begin HCV treatment. The described outcomes appear promising for reaching the vision of linkage to the care of such a hard-to-reach population and can serve as a feasible model of care for further expansion. MDPI 2022-12-28 /pmc/articles/PMC9819867/ /pubmed/36612821 http://dx.doi.org/10.3390/ijerph20010501 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Krekulová, Laura
Damajka, Tomáš
Krumphanslová, Zuzana
Řehák, Vratislav
Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
title Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
title_full Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
title_fullStr Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
title_full_unstemmed Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
title_short Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
title_sort pilot outreach program in remedis—the promising step toward hcv elimination among people who inject drugs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819867/
https://www.ncbi.nlm.nih.gov/pubmed/36612821
http://dx.doi.org/10.3390/ijerph20010501
work_keys_str_mv AT krekulovalaura pilotoutreachprograminremedisthepromisingsteptowardhcveliminationamongpeoplewhoinjectdrugs
AT damajkatomas pilotoutreachprograminremedisthepromisingsteptowardhcveliminationamongpeoplewhoinjectdrugs
AT krumphanslovazuzana pilotoutreachprograminremedisthepromisingsteptowardhcveliminationamongpeoplewhoinjectdrugs
AT rehakvratislav pilotoutreachprograminremedisthepromisingsteptowardhcveliminationamongpeoplewhoinjectdrugs